edward lifesci pois anoth year robust
growth thank tavr
page full analyst note feb
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research feb
estim oct
price data feb
rate updat feb
currenc amount express
valuat growth profit
methodolog valu compani
sinc spin baxter
demonstr know stick knit tissu heart
valv edward maintain domin surgic heart valv
pioneer new minim invas heart valv therapi -- one
hottest area cardiac devic
edward done good job refocus higher-margin
product shed non-core busi effort result
impress gross margin improv
sinc becom stand-alon compani although firm
significantli smaller close competitor abbott
term sale remain global leader core busi
tissu heart valv command global
market firm maintain leadership posit critical-car
monitor equip complement heart valv
edward regularli engag serial acquisit
firm occasion augment
research
develop effort select purchas technolog
firm posit lead edg come
transcathet heart valv dual franchis balloon-expand
self-expand valv edward robust
transcathet aortic valv pipelin firm also remain
lead develop transcathet mitral valv product edward
pois ride wave new technolog shift valv
replac transcathet approach especi
clinic data support efficaci safeti product
condit
said still anticip bump road
edward alreadi taken shot transcathet mitral valv
littl success challeng area given
econom behind
transcathet aortic valv replac remain less attract
surgic valv mani hospit though eas recent
market also becom crowd
abbott fray nonetheless think
long-term clinic trend shift toward transcathet
technolog edward sit pretti
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
spun design
manufactur market rang medic devic equip
advanc stage heart diseas key product includ tissu heart
valv surgic clip cathet retractor monitor system use
measur patient heart function surgeri firm deriv
total sale outsid
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
edward lifesci pois anoth year
robust growth thank tavr feb
edward lifesci finish strong fashion
expect moder rais fair valu estim
reflect margin expans favor product mix
shift lower-than-expect effect tax rate
well time valu money remain confid
edward narrow econom moat firm prepar
launch sapien ultra deliveri system europ
 year european regulatori approv
centera self-expand tavr product firm remain
lead edg tavr innov addit
centera offer broadest rang tavr devic
edward full-year result close estim
top bottom line sale growth
transcathet heart valv consist
project surgic valv critic care
slightli exceed estim though
materi factor move valuat project
continu double-digit growth tavr franchis
put estim total revenu growth near
top manag outlook pleas hear
 contribut
disproportion quarterli tavr growth
addit new center slow
significantli adopt technolog increas
patient volum key factor support robust
growth go forward contend recent indic
expans includ intermediate-risk eventu low-
risk patient keep underli demand healthi
although commerci transcathet mitral valv
technolog remain edward make
progress rang tmv platform enrol
 trial cardioband continu enrol
pascal expect begin later year given
cardioband alreadi approv use europ
come quarter give us earli peek recept
practition technolog whether
ease-of-us issu emerg
develop transcathet mitral valv technolog
key cardiac devic maker pursu innov
pleas see report chang heart renew interest
among cardiac devic maker transcathet mitral
valuat growth profit apr
modestli rais fair valu estim
per share adjust sapien
project upward reflect recent
clinic data establish noninferior
corevalv gold-standard surgic valv replac
demonstr superior sapien savr give
leg competit think data help
practition feel comfort turn transcathet
aortic valv high- intermediate-risk patient
expand patient pool estim patient
also expect new medicar code specif
transcathet valv replac add topspin
uptak next year importantli think
edward eventu captur subseg
high-risk surgic patient intermediate-risk
patient base recent favor clinic data expect
oper margin hold steadi abbott boston
scientif enter market time frame
project sapien perform remain heart
valuat expect sapien growth
take account recent strength next-gener
launch new clinic data could sway practition
toward sapien new reimburs code
gone effect transcathet valv franchis
drive low-double-digit top-lin growth edward
gross margin gain mix shift
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
nearli billion oper margin would
hover averag annual revenu
growth adjust earn growth
scenario bring fair valu estim per
hand see share loss abbott
boston scientif along
aggress price pressur -- expect growth
transcathet heart valv sale sapien franchis sale
would reach billion oper
margin would peak assumpt
would see top-lin growth price pressur
requir invest research develop
would keep earn growth averag would
slice valuat per share
despit compet rather matur surgic heart valv
market come domin tissu
valv thu dig narrow moat compani long
histori pioneer new heart valv still highli
regard cardiac surgeon technolog advanc
edward compet abbott primarili mechan heart
valv howev edward remain
heavi hitter tissu valv segment like mani
devic compani edward compet basi
technolog innov intellectu properti close
relationship physician
recent edward
forg ahead
technolog innov give heart valv market
jolt develop minim invas aortic heart valv
instal cathet therebi make
procedur recoveri much easier patient current
tradit valv requir extens surgic procedur
implant mean estim half one third
elderli patient need valv replac
frail high-risk undergo surgic valv replac
alreadi taken place past year royalti
payment offer anoth boost
expect gross margin hold steadi
rang medium term project oper
margin remain around next five year
domest price pressur exacerb
expect new entrant emerg may need revisit
assumpt year total think
increas
compound annual
incom
base rel narrow concentr product
portfolio edward rate firm uncertainti high
recogn may substanti upsid patient
pool tavr expand includ intermediate-risk
patient european competit remain peripher
reimburs europ quicken case
sketch bull scenario st jude boston
unabl grow major tavr rival
unabl address heart-rhythm complic associ
corevalv condit would drive tavr sale
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
believ edward bolster leadership posit
tissu heart valv sapien transcathet aortic valv
franchis tavr deliv either
femor arteri similar angioplasti small
hole two rib minim invas therapi
would potenti tap estim american
patient current
inoper high-risk
candid tradit valv surgeri expect
technolog adopt wide patient pool
expand includ intermediate- low-risk patient
time trial data amass
stand behind stabl moat trend rate
edward expect continu technolog innov
help counter grow threat competit
edward global leader tissu heart valv
less invas technolog put ahead competitor
edward two-year lead pioneer categori
transcathet heart valv -- one hottest develop
excit intervent cardiologist heart
surgeon alik addit edward alreadi launch
 -- regulatori approv japan put commerci launch
docket market -- enhanc make
even thinner virtual elimin sever valve-leakag
complic affect patient
earlier technolog compani success
develop transcathet mitral valv technolog think
europ
transcathet valv everywher st jude medic
enter europ
surfac despit edward head start
geographi firm need offer meaning
innov regular basi keep leadership posit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
oedward effort focu effici higher-
margin product paid gross margin
increas
ocardiothorac surgeon fairli conserv
bunch like stick proven devic brand
pioneer heart valv edward continu
seen gold standard
oedward benefit age popul
experi problem heart valv
congest heart failur greater frequenc
oedward ambit diversifi
minim
invas medic technolog place firm direct
competit much larger competitor
abbott easili bid price
emerg technolog edward
ocompetit abbott like
enter market start time
oif sapien price remain high even entranc
new rival payer may limit usag transcathet
valv intermediate-risk patient
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
edward light debt leverag larg cash invest
posit give firm financi flexibl end
decemb edward major debt outstand
consist million senior unsecur note due
firm sat billion cash
invest follow recent cardiaq valtech
acquisit bolster mitral valv pipelin gross
debt/ebitda stood time interest
coverag time view share repurchas
like use edward excess financi resourc
time manag indic prudent
prefer make repurchas time
share look attract valu marketplac
first half edward spent million
repurchas compani pay dividend
merger acquisit strategi also remain rel
conserv edward typic use intern research
develop effort smaller acquisit expand
product offer edward ride high growth
wave transcathet valv expect abl
easili fund growth support strateg acquisit
financi resourc cash flow unless
firm becom enamor
opportun someth view unlik
anticip major chang easili manag capit
edward heart valv still requir major surgeri
implant medic industri
move toward minim invas procedur cut
recoveri time cost although edward current
enjoy duopoli transcathet aortic valv
 new competitor horizon
still work lotu transcathet
valv recent acquir new self-expand tavr
technolog though think boston trail edward
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
medtron two three year firm prove
formid competitor cardiac devic market
clinic outcom sapien valv longer term
yet assess preliminari data hint
substanti portion elderli patient popul would
expir anyway independ caus within
sever year even implant sapien valv
rais question medicar appetit reimburs
expens devic put pressur tavr
manufactur demonstr econom valu
technolog final edward could see competit
surgic tool busi minim invas surgic
system maker enter cardiac
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
repres date owner name posit common share held report holder issuer
govern pension fund norway global
share
fund
share
fund
think edward stewardship solid assign
presid baxter michael mussallem ceo
chairman edward sinc spin-off offer
steadi presenc helm mussallem receiv
reason compens like goal
bonu place emphasi revenu growth -- key
object compani histor particip
slower-grow market -- free cash flow growth
net incom also taken consider think
often subject account manipul
would like see even greater detail specif
measur mussallem judg pleas
edward reli restricted-stock unit vest
five year rather stock option alon
encourag mussallem manag edward eye
toward longer term like succession-plan
updat provid board meet ensur
board highli involv survey manag talent
potenti execut posit think firm
overal corpor govern polici well design
corporate-alloc standpoint edward made
wise decis unlik larger rival edward
reli heavili serial acquisit instead
first prioriti plow resourc intern innov
kept surgic heart valv busi
leadership posit despit categori slow growth
one major acquisit edward made percutan
valv technolog million includ mileston
payment laid foundat edward
sapien technolog addit pvt catapult edward
race enter tavr market first edward
might lucki purchas mani
early-stag technolog end gutter ball
nevertheless edward enjoy strong posit
categori project grow billion edward
recent acquisit cardiaq valtech
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
bolster firm invest transcathet mitral valv
therapi even though commerci technolog
could take year think edward strong posit
pursu market
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
surgic mitral valv wouldnt bet hors
edward deliv solid growth chang
perform consist expect
despit fall short consensu project
maintain fair valu estim narrow-moat
compani firm remain track meet full-year
estim underli sale sapien around
quarter train center move beyond
surpris see transcathet aortic valv replac
growth tavr slow year remain
comfort high-teen growth weve project
 close manag guidanc
growth go forward think expans
pool includ intermediate-risk patient
translat steadi stream procedur
patient learn technolog practition becom
comfort refer tavr
edward cusp launch new tavr technolog
europ underscor strength firm
narrow econom moat edward continu enjoy
widest portfolio transcathet technolog
opinion streamlin sapien ultra system
self-expand centera tavr expect receiv
sapien innov continu offer improv
favor impact practition effici
complic rate addit centera mean
edward firm offer balloon-
expand self-expand platform beyond near-
term launch edward continu work host
repair product approach replac
havent bake tmv assumpt model
recogn edward remain lead hors race
success commerci tmv
replac consid firm long histori
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
